Stocks

ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1
June 23, 2020 03:35 PM AEST| By Team Kalkine MediaThe healthcare sector across the world is struggling with the myriad challenges thrown by the COVID-19 pandemic, and virtual healthcare is fast becoming the global response of private as well as the public healthcare system to the SARS-CoV-2 outbre.....

ASX biotech companies creating a pandemic-free buzz!
June 21, 2020 12:00 AM AEST| By Team Kalkine MediaAs on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide. And with no sign to the ending of this human loss, an indispensable need for a vaccine or a treatment has .....

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and API
June 16, 2020 06:57 PM AEST| By Team Kalkine MediaThe healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medical devices, drugs, and services. The healthcare system in Australia is one of the most robust ones.....

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovation, Boost R&D Efforts
June 12, 2020 02:49 PM AEST| By Team Kalkine MediaIn the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities, while the more prominent players handle the marketing and commercialisation activities as they h.....

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1
June 11, 2020 02:53 PM AEST| By Team Kalkine MediaSmall-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are plenty of promising investment opportunities. Despite their smaller size, small-cap stocks have s.....

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASCO 2020 Annual Meeting
June 03, 2020 11:42 AM AEST| By Team Kalkine MediaSummary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at ASCO 2020 Annual Meeting. Highly encouraging interim data from the Phase 1b/2a LuPIN clinical trial.....

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2 Million
April 17, 2020 01:14 PM AEST| By Team Kalkine MediaAustralian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcomes for the March quarter 2020. The Company is engaged in the development of new drugs that demonstr...

Lens over SUDA’s Operational Highlights in 1H FY20
March 04, 2020 01:59 PM AEDT| By Hina ChowdharyContinuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declared results for the half-year period ended 31st December 2019. The Company continued to focus on attr...

Latest Brand Enhancements at Consumer Powerhouse-Pental Limited
February 12, 2020 07:18 PM AEDT| By Team Kalkine MediaA renowned ASX-listed consumer staples company producing some of the world’s most recognisable brands, Pental Limited (ASX:PTL) is a full end-to-end service provider of consumer goods in Australia, New Zealand and Asia. The Company is the larg...

AuMake Ensures Contracts Will Be Met Despite Coronavirus Outbreak
January 29, 2020 08:55 PM AEDT| By Hina ChowdharyThe stock markets around the world have retreated with the fears prevailing around the fallout on global growth outlook due to China's coronavirus outbreak. On 25 January 2020, China’s Ministry of Culture and Tourism enforced greater travel re...

Why is the THC Global share price rocketing higher?
January 21, 2020 06:19 PM AEDT| By Team Kalkine MediaMarijuana stocks or pot stocks are catching investors eyes these days after the legalisation of cannabis for medicinal and recreational use in many countries. According to Australian health department all the cannabis formulations such as tinctures,...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx
January 15, 2020 04:50 PM AEDT| By Hina ChowdharyIt’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in the largest pharmaceutical market of the world. The United States Patent and Trademark Office (USPTO...

Emergence of new Bellamy's? Wattle Health Story
January 03, 2020 07:03 PM AEDT| By Team Kalkine MediaWattle Health Australia Limited (ASX: WHA) Wattle Health is rapidly undertaking decisions to scale up its reach and presence. The company has taken decisions, including new CEO appointment, partnerships, supply agreement, capital raising etc...

Prescient Collaborates with Carina Biotech in Expansion into Exciting CAR-T Therapies
December 10, 2019 04:19 PM AEDT| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targeted therapy approach to target individual tumour variability rather than the conventional one size...

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics
November 25, 2019 06:06 PM AEDT| By Team Kalkine MediaHealth care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology. Health care sector comprises of providers of medical services, medical insurance, and medical equip...

Online Screening and Verification Company, CVCheck’s new B2B wins Drive Record Revenue in Q1FY20
October 30, 2019 06:01 PM AEDT| By Team Kalkine MediaCVCheck Limited (ASX: CV1) is a young and expanding information technology company based in Australia with growing revenue streams. It provides people screening and verification services to a multitude of clients including employers, industry associa...

Hits & Misses for the four Major Banks – ANZ, CBA, NAB, WBC
October 09, 2019 03:09 PM AEDT| By Team Kalkine MediaIn Australia, the banking industry is dominated by the four major banks that include Australia & New Zealand Banking Group Limited (ASX: ANZ), Commonwealth Bank of Australia (ASX: CBA), National Australia Bank Limited (ASX: NAB), and Westpac Bank...

Are Dividend Cuts On The Cards For The Bank Stocks?
September 16, 2019 02:05 PM AEST| By Team Kalkine MediaApart from idiosyncratic headwinds towards each of the bank, there is one pervasive obstacle that the earnings of banking players might witness - would be a few dents in the coming time, as the current world is going through the global easing cycle....

Online Cyber Security Exchange, WhiteHawk Limited – Latest developments not to be missed!
September 04, 2019 04:32 PM AEST| By Team Kalkine MediaThe first online cyber security exchange across the world, WhiteHawk Limited (ASX: WHK) is an Australian-headquartered firm allowing SMEs to take smart measures against fraud and cybercrime. It is a cloud-based cyber security exchange platform that o...

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market
August 20, 2019 04:36 PM AEST| By Team Kalkine MediaImugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to enable a patient?s immune system to recognise and destroy cancer cells. The company is focused on targe...

Advertise your brand on Kalkine Media